Monitoring, Immunologic: Clinical Trials

5 trials of Monitoring, Immunologic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 terminated, 1 not yet recruiting. 2 Phase 2, 1 Not applicable, 1 Phase 1, 1 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Not yet recruiting 1
Not applicable1Terminated 1
Phase 11Terminated 1
Phase 41Completed 1

Follow Monitoring, Immunologic: new trials by email Literature Review of Monitoring, Immunologic trials Research Report on Monitoring, Immunologic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue Cancer
Lingual Nerve Disruption, Tislelizumab, Albumin-bound Paclitaxel - Tongue Squamous Cell Carcinoma
Phase 2Not yet recruitingShanghai Zhongshan Hospital692026-01-012026-01-16
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
Neoantigen Peptide Vaccine, Poly ICLC, Blood for immune monitoring - Pancreas Cancer, Pancreatic Cancer
Phase 1TerminatedWashington University School of Medicine122020-02-132024-07-17
Adjuvant Therapy of Skin Melanoma With Alpha Interferon and Naderin
Surgical resection, Adjuvant Radiotherapy, interferon alfa - Melanoma Stage I, Melanoma Stage III
Phase 2CompletedMIPO Clinic2782014-01-012026-06-30
Reference Group Trial for The ONE Study
Blood drawing for immune monitoring and questionnaires - End-stage Renal Failure, Kidney Graft Rejection
Phase 4CompletedUniversity of Regensburg702012-12-012016-03-09
NIH Substudy of AIN457 (Anti-IL-17 Monoclonal Antibody) for Treatment of Moderate to Severe Crohn's Disease
Immunologic Monitoring - Colitis, Crohn's Disease
Not applicableTerminatedNational Institutes of Health Clinical Center (CC)22009-07-012016-01-11

Conditions studied

Colitis (1)  ·  Crohn Disease (1)  ·  Inflammatory Bowel Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Melanoma (1)  ·  Pancreatic Neoplasms (1)

Sponsors

MIPO Clinic (1)  ·  National Institutes of Health Clinical Center (CC) (1)  ·  Shanghai Zhongshan Hospital (1)  ·  University of Regensburg (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  China (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  United Kingdom (1)

Top investigators

Edward K. Geissler, Ph.D. (1)  ·  Michael D Yao, MD (1)  ·  William E Gillanders, M.D. (1)

Results publications

PMID 32446407, PMID 36306921, PMID 36441083

NIH funding

P50CA196510 (1)